GRWD1 and cancer: Indeed, our results show that GRWD1 dysregulation is associated with poor prognosis of patients in several types of cancer (24), including brain lower-grade glioma (LGG), mesothelioma (MESO), and skin cutaneous melanoma (SKCM).